subject area of
- A Long-term Study of the Antiinflammatory Effect of Low-dose Budesonide Plus Formoterol versus High-dose Budesonide in Asthma Journal Articles
- A Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthma Journal Articles
- A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma Journal Articles
- Acute asthma intervention: Insights from the STAY study Journal Articles
- Adding formoterol to budesonide in moderate asthma—health economic results from the FACET study Journal Articles
- Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five‐Month Multicentre Canadian Study Journal Articles
- Advances in the treatment of mild asthma: recent evidence Journal Articles
- An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma Journal Articles
- As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma Journal Articles
- Asthma quality of life during 1 year of treatment with budesonide with or without formoterol Journal Articles
- Attenuation of Age-Related Muscle Wasting and Weakness in Rats After Formoterol Treatment: Therapeutic Implications for Sarcopenia Journal Articles
- Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma Journal Articles
- Budesonide/formoterol maintenance and reliever therapy versus conventional best practice Journal Articles
- Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma Journal Articles
- Canadian Economic Evaluation of Budesonide‐Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma Journal Articles
- Chronic β2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity Journal Articles
- Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction Journal Articles
- Cost-effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain Journal Articles
- Daily Inhaled Corticosteroid Treatment Should Be Prescribed for Mild Persistent Asthma Journal Articles
- Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations Journal Articles
- Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma Journal Articles
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma Journal Articles
- Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study Journal Articles
- Effect of different asthma treatments on risk of cold-related exacerbations Journal Articles
- Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma Journal Articles
- Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators Journal Articles
- Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma Conferences
- Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment Journal Articles
- Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro Journal Articles
- Exacerbations of Asthma Journal Articles
- Formoterol Compared with Beclomethasone and Placebo on Allergen-induced Asthmatic Responses Journal Articles
- Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial Journal Articles
- Formoterol as reliever medication in asthma: a post-hoc analysis of the subgroup of the RELIEF study in East Asia Journal Articles
- How much is too much? The treatment of mild asthma Journal Articles
- Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control Journal Articles
- Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma Journal Articles
- Intramuscular β2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury Journal Articles
- Long-acting -agonists: a review of formoterol safety data from asthma clinical trials Journal Articles
- Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma Journal Articles
- Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue Journal Articles
- Measuring asthma control: a comparison of three classification systems Journal Articles
- Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps Journal Articles
- Overall asthma control: The relationship between current control and future risk Journal Articles
- Pharmacological management of mild or moderate persistent asthma Journal Articles
- Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2 Journal Articles
- Potentiation of long-acting β2-agonist and glucocorticoid responses in human airway epithelial cells by modulation of intracellular cAMP Journal Articles
- Prolonged Protection against Methacholine-induced Bronchoconstriction by the Inhaled β2-Agonist Formoterol Journal Articles
- Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators Journal Articles
- Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events Journal Articles
- Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events Journal Articles
- Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids Journal Articles
- Safe use of long-acting β-agonists: what have we learnt? Journal Articles
- Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies Journal Articles
- Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials Journal Articles
- Safety of formoterol in asthma clinical trials: an update Journal Articles
- The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility? Journal Articles
- The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials Journal Articles
- The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge Conferences
- The management of mild asthma Journal Articles
- The paradoxes of asthma management: time for a new approach? Journal Articles
- The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta‑analysis Journal Articles
- Treatment Strategy for Asthma Journal Articles
- What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever? Journal Articles